Compare IVVD & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | NXRT |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.8M | 787.8M |
| IPO Year | 2021 | N/A |
| Metric | IVVD | NXRT |
|---|---|---|
| Price | $1.75 | $30.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $8.75 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 3.3M | 182.8K |
| Earning Date | 03-19-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 7.02% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $50,039,000.00 | ★ $253,196,000.00 |
| Revenue This Year | $107.86 | N/A |
| Revenue Next Year | $146.53 | $2.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 332.71 | N/A |
| 52 Week Low | $0.35 | $27.69 |
| 52 Week High | $3.07 | $43.13 |
| Indicator | IVVD | NXRT |
|---|---|---|
| Relative Strength Index (RSI) | 30.35 | 48.92 |
| Support Level | $2.15 | $29.47 |
| Resistance Level | $2.31 | $30.49 |
| Average True Range (ATR) | 0.17 | 0.65 |
| MACD | -0.07 | -0.09 |
| Stochastic Oscillator | 3.81 | 27.59 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.